Enrocare 50 mg/ml Solution for Injection for Cattle, Pigs, Dogs and Cats

Šalis: Airija

kalba: anglų

Šaltinis: HPRA (Health Products Regulatory Authority)

Veiklioji medžiaga:

Enrofloxacin

Prieinama:

Emdoka bvba

ATC kodas:

QJ01MA90

INN (Tarptautinis Pavadinimas):

Enrofloxacin

Dozė:

50 milligram(s)/millilitre

Vaisto forma:

Solution for injection

Recepto tipas:

POM: Prescription Only Medicine as defined in relevant national legislation

Gydymo sritis:

enrofloxacin

Autorizacija statusas:

Authorised

Leidimo data:

2013-09-27

Prekės savybės

Health Products Regulatory Authority
27 February 2019
CRN008W34
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Enrocare 50 mg/ml Solution for Injection for Cattle, Pigs, Dogs and
Cats
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml of the solution for injection contains:
ACTIVE SUBSTANCE:MG
Enrofloxacin 50
EXCIPIENTS:
Butyl alcohol as antimicrobial preservative 30
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
Clear, light yellow, sterile, aqueous solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle (calves)
Pigs weighing more than 25kg
Dogs and cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Calves
Treatment of infections of the respiratory tract caused by
enrofloxacin susceptible strains of _Pasteurella multocida,
Mannheimia_
_haemolytica _and _Mycoplasma _spp.
Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of _Escherichia coli_.
Treatment of septicaemia caused by enrofloxacin susceptible strains of
_Escherichia coli_.
Treatment of acute mycoplasma-associated arthritis due to enrofloxacin
susceptible strains of _Mycoplasma bovis_.
Pigs
Treatment of infections of the respiratory tract caused by
enrofloxacin susceptible strains of _Pasteurella multocida, Mycoplasma
_
spp. and _Actinobacillus pleuropneumoniae_.
Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of _Escherichia coli_.
Treatment of septicaemia caused by enrofloxacin susceptible strains of
_Escherichia coli. _
Dogs
Treatment of infections of the alimentary, respiratory and urogenital
tracts (including prostatitis, adjunctive antibiotic therapy
for pyometra), skin and wound infections, otitis (externa/media)
caused by enrofloxacin susceptible strains of _Staphylococcus _
spp_., Escherichia coli, Pasteurella _spp_., Klebsiella _spp_.,
Bordetella _spp_., Pseudomonas _spp_. _and _Proteus _spp_. _
Cats
Treatment of infections of the alimentary, respiratory and uroge